tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market
Advertisement

Zelira Therapeutics (ZLDAF) Technical Analysis

Compare
16 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Zelira Therapeutics’s (ZLDAF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Zelira Therapeutics is a Buy.
Zelira Therapeutics’s (ZLDAF) 20-Day exponential moving average is 0.27, while Zelira Therapeutics’s (ZLDAF) share price is $0.26, making it a Sell.
Zelira Therapeutics’s (ZLDAF) 50-Day exponential moving average is 0.27, while Zelira Therapeutics’s (ZLDAF) share price is $0.26, making it a Sell.

Zelira Therapeutics (ZLDAF) Pivot Points

Jul 31, 2025, 05:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Fibonacci
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLDAF) Moving Averages

Jul 31, 2025, 05:24 AM
Period
Simple
Exponential
MA5
0.27Sell
0.26Sell
MA10
0.27Sell
0.27Sell
MA20
0.27Sell
0.27Sell
MA50
0.26Sell
0.27Sell
MA100
0.28Sell
0.29Sell
MA200
0.34Sell
0.34Sell
Zelira Therapeutics’s (ZLDAF) 10-Day exponential moving average is 0.27, while Zelira Therapeutics’s (ZLDAF) share price is $0.26, making it a Sell.
Zelira Therapeutics’s (ZLDAF) 100-Day exponential moving average is 0.29, while Zelira Therapeutics’s (ZLDAF) share price is $0.26, making it a Sell.
Zelira Therapeutics’s (ZLDAF) stock price is $0.26 and Zelira Therapeutics’s (ZLDAF) 50-day simple moving average is 0.26, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.26 and Zelira Therapeutics’s (ZLDAF) 100-day simple moving average is 0.28, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.26 and Zelira Therapeutics’s (ZLDAF) 200-day simple moving average is 0.34, creating a Sell signal.

Zelira Therapeutics (ZLDAF) Technical Indicators

Jul 31, 2025, 05:24 AM
Name
Value
Implied Action
RSI (14)
22.63
Buy
STOCH (9,6)
11.11
Buy
STOCHRSI (14)
11.11
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
28.46
Neutral
Williams %R
-83.33
Buy
CCI (14)
-205.46
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
31.05
Neutral
ROC
-3.70
Sell
Zelira Therapeutics’s (ZLDAF) Relative Strength Index (RSI) is 22.63, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) Trend Strength Indicator (ADX) is 28.46, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Commodity Channel Index (CCI) is -205.46, creating a Buy signal.
Zelira Therapeutics’s (ZLDAF) Price Rate of Change (ROC) is -3.70, creating a Sell signal.

FAQ

Is ZLDAF a Buy, Hold, or Sell?
Based on ZLDAF’s technical indicators, ZLDAF is a Sell.
    What is ZLDAF’s RSI (14)?
    ZLDAF’s RSI (14) is 22.63, which suggests ZLDAF is a Buy.
      What is ZLDAF’s MACD?
      ZLDAF’s MACD is >-0.01, which suggests ZLDAF is a Buy.
        What is ZLDAF’s 5-day moving average?
        ZLDAF’s 5-day moving average is 0.27, which suggests ZLDAF is a Sell.
          What is ZLDAF’s 20-day moving average?
          ZLDAF 20-day moving average is 0.27, which suggests ZLDAF is a Sell.
            What is ZLDAF’s 50-day moving average?
            ZLDAF’s 50-day moving average is 0.26, which suggests ZLDAF is a Sell.
              What is ZLDAF’s 200-day moving average?
              ZLDAF’s 200-day moving average is 0.34, which suggests ZLDAF is a Sell.
                What is ZLDAF’s Williams % R (14)?
                ZLDAF’s Williams % R (14) is -83.33, which suggests ZLDAF is a Buy.
                  What is ZLDAF’s CCI (14)?
                  ZLDAF’s CCI (14) is -205.46, which suggests ZLDAF is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis